Oxford Biomedica (OXB) Insider Trading & Ownership GBX 425.50 +4.50 (+1.07%) (As of 12:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Oxford Biomedica (LON:OXB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.17%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)£212,166.87Number OfInsiders Selling(Last 3 Years)0 Get OXB Insider Trade Alerts Want to know when executives and insiders are buying or selling Oxford Biomedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OXB Insider Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Oxford Biomedica Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/13/2023Michael HaydenInsiderBuy10,000GBX 193£19,3009/26/2023Dame Kay DaviesInsiderBuy1,000GBX 291£2,9109/20/2023Roch DoliveuxInsiderBuy36,130GBX 274£98,996.207/3/2023Catherine MoukheibirInsiderBuy6,684GBX 430£28,741.2010/11/2022Catherine MoukheibirInsiderBuy8,910GBX 317£28,244.704/29/2022Catherine MoukheibirInsiderBuy2,467GBX 571£14,086.574/20/2022Stuart PaynterInsiderBuy3,915GBX 508£19,888.20 (Data available from 1/1/2013 forward) OXB Insider Trading Activity - Frequently Asked Questions Who is on Oxford Biomedica's Insider Roster? The list of insiders at Oxford Biomedica includes Catherine Moukheibir, Dame Kay Davies, Michael Hayden, Roch Doliveux, and Stuart Paynter. Learn more on insiders at OXB. What percentage of Oxford Biomedica stock is owned by insiders? 21.17% of Oxford Biomedica stock is owned by insiders. Learn more on OXB's insider holdings. Which Oxford Biomedica insiders have been buying company stock? The following insiders have purchased OXB shares in the last 24 months: Catherine Moukheibir (£28,741.20), Dame Kay Davies (£2,910), Michael Hayden (£19,300), and Roch Doliveux (£98,996.20). How much insider buying is happening at Oxford Biomedica? Insiders have purchased a total of 53,814 OXB shares in the last 24 months for a total of £149,947.40 bought. Oxford Biomedica Key ExecutivesMr. Stuart Paynter (Age 52)CFO & Director Compensation: $832kDr. Frank Mathias (Age 62)CEO & Director Mr. Thierry CournezCOO & Oxford Site HeadDr. James Miskin Ph.D.Chief Quality & Technical OfficerMr. Matthew TreagusChief Information OfficerSophia BolhassanHead of Investor RelationsMs. Natalie Louise Walter (Age 51)General Counsel & Company Secretary Ms. Lisa JamesChief People OfficerDr. Kyriacos Mitrophanous Ph.D.Chief Innovation OfficerMs. Kati HudsonHead of Intellectual Property and Contracts More Insider Trading Tools from MarketBeat Related Companies Oxford Nanopore Technologies Insider Selling Genus Insider Selling Arix Bioscience Insider Selling Bioventix Insider Selling 4basebio Insider Selling e-therapeutics Insider Selling Tissue Regenix Group Insider Selling Poolbeg Pharma Insider Selling Sareum Insider Selling Oncimmune Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:OXB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
